Stegeman CA - Search Results

1

Targeting NF-κB signaling in B cells as a potential new treatment modality for ANCA-associated vasculitis.

Merino-Vico A, van Hamburg JP, Tuijnenburg P, Frazzei G, Al-Soudi A, Bonasia CG, Helder B, Rutgers A, Abdulahad WH, Stegeman CA, Sanders JS, Bergamaschi L, Lyons PA, Bijma T, van Keep L, Wesenhagen K, Jongejan A, Olsson H, de Vries N, Kuijpers TW, Heeringa P, Tas SW. Merino-Vico A, et al. Among authors: stegeman ca. J Autoimmun. 2024 Jan;142:103133. doi: 10.1016/j.jaut.2023.103133. Epub 2023 Nov 8. J Autoimmun. 2024. PMID: 37931331 Free article.

2

Protective role of endothelial nitric oxide synthase.

Albrecht EW, Stegeman CA, Heeringa P, Henning RH, van Goor H. Albrecht EW, et al. Among authors: stegeman ca. J Pathol. 2003 Jan;199(1):8-17. doi: 10.1002/path.1250. J Pathol. 2003. PMID: 12474221 Review.

3

New insights into the pathogenesis of antineutrophil cytoplasmic autoantibody-associated vasculitis.

Kallenberg CG, Rarok A, Stegeman CA, Limburg PC. Kallenberg CG, et al. Among authors: stegeman ca. Autoimmun Rev. 2002 Feb;1(1-2):61-6. doi: 10.1016/s1568-9972(01)00008-8. Autoimmun Rev. 2002. PMID: 12849060 Review.

4

The Th1 and Th2 paradigm in ANCA-associated vasculitis.

Sanders JS, Stegeman CA, Kallenberg CG. Sanders JS, et al. Among authors: stegeman ca. Kidney Blood Press Res. 2003;26(4):215-20. doi: 10.1159/000072987. Kidney Blood Press Res. 2003. PMID: 14504420 Review.

5

ANCA-GBM dot-blot: evaluation of an assay in the differential diagnosis of patients presenting with rapidly progressive glomerulonephritis.

Rutgers A, Damoiseaux J, Roozendaal C, Limburg PC, Stegeman CA, Tervaert JW. Rutgers A, et al. Among authors: stegeman ca. J Clin Immunol. 2004 Jul;24(4):435-40. doi: 10.1023/B:JOCI.0000029115.79266.ae. J Clin Immunol. 2004. PMID: 15163900

6

Risk factors for relapse in anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis: tools for treatment decisions?

Sanders JS, Stassen PM, van Rossum AP, Kallenberg CG, Stegeman CA. Sanders JS, et al. Among authors: stegeman ca. Clin Exp Rheumatol. 2004;22(6 Suppl 36):S94-101. Clin Exp Rheumatol. 2004. PMID: 15675143 Review.

7

Persistent expansion of CD4+ effector memory T cells in Wegener's granulomatosis.

Abdulahad WH, van der Geld YM, Stegeman CA, Kallenberg CG. Abdulahad WH, et al. Among authors: stegeman ca. Kidney Int. 2006 Sep;70(5):938-47. doi: 10.1038/sj.ki.5001670. Epub 2006 Jul 12. Kidney Int. 2006. PMID: 16837919 Free article.

8

Mechanisms of Disease: pathogenesis and treatment of ANCA-associated vasculitides.

Kallenberg CG, Heeringa P, Stegeman CA. Kallenberg CG, et al. Among authors: stegeman ca. Nat Clin Pract Rheumatol. 2006 Dec;2(12):661-70. doi: 10.1038/ncprheum0355. Nat Clin Pract Rheumatol. 2006. PMID: 17133251 Review.

9

Staphylococcal toxic-shock-syndrome-toxin-1 as a risk factor for disease relapse in Wegener's granulomatosis.

Popa ER, Stegeman CA, Abdulahad WH, van der Meer B, Arends J, Manson WM, Bos NA, Kallenberg CG, Tervaert JW. Popa ER, et al. Among authors: stegeman ca. Rheumatology (Oxford). 2007 Jun;46(6):1029-33. doi: 10.1093/rheumatology/kem022. Epub 2007 Apr 4. Rheumatology (Oxford). 2007. PMID: 17409134

10

Functional defect of circulating regulatory CD4+ T cells in patients with Wegener's granulomatosis in remission.

Abdulahad WH, Stegeman CA, van der Geld YM, Doornbos-van der Meer B, Limburg PC, Kallenberg CG. Abdulahad WH, et al. Among authors: stegeman ca. Arthritis Rheum. 2007 Jun;56(6):2080-91. doi: 10.1002/art.22692. Arthritis Rheum. 2007. PMID: 17530650 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

261 results

Search Page

Filters